On November 21, 2022, Aurora Healthcare US Corp (“Aurora”) and GoodDoctor Pharmaceutical Group (“Good Doctor”) reached a strategic cooperation to integrate the advantages of both sides in the field of breast cancer diagnosis and traditional Chinese medicine treatment, and jointly innovate the breast cancer prevention, diagnosis, treatment and rehabilitation integrated service system based on the combination of Chinese and western medicine. The two sides will work together to build breast center chain back-up headquarters for the whole-cycle of breast health services; take the lead in recruiting 50 breast centers to join in Yunnan, Guizhou, Sichuan, and Chongqing; create the "Good Doctor-Aurora" breast health service brand; let Good Doctor to expand the international market of traditional Chinese medicine represented by "Yandong (延动)" through evidence-based medicine. Mr. Geng Fu-Neng (耿福能), Chairman of Good Doctor, Ms. Olivia Ho Cheng (何淑圭), CEO of Aurora, and other essential guests from both sides participated in witnessing the signing ceremony.

Currently, breast cancer has become the largest cancer threat to women in China. The improvement of the early screening, early diagnosis, and early treatment system of breast cancer is a significant issue for women's health.

As a medical group specializing in manufacturing breast MRI systems, Aurora has been committed to women's breast health for more than 20 years. It has experience in building nearly 70 breast centers worldwide. In China, the first independent breast center was established with Sichuan Provincial People's Hospital, which has accumulated valuable experience in exploring the integrated breast health service system of "prevention, diagnosis, treatment and rehabilitation" by providing services featuring breast diseases.

Good Doctor is a leading "Big Health" industry group in China with Chinese medicine as the core. Its Chinese medicine products such as "Yandong (延动)" and "Kangfuxin Ye (康复新液)" are in the leading position in China, with a broad potential for internationalization. The group has developed for 36 years, and its network terminals cover Yunnan, Guizhou, Sichuan and Chongqing intensively.

Aurora has reached a strategic cooperation with Good Doctor, which will jointly create an overall solution for whole-cycle breast health services based on the combination of traditional Chinese and western medicine, form a standardized breast cancer prevention, diagnosis, treatment and rehabilitation service system, and take the lead in recruiting 50 breast centers in Yunnan, Guizhou, Sichuan, and Chongqing. These standardized breast centers will take advantage of Aurora's dedicated breast MRI in the early detection of breast cancer to improve the early screening and early diagnosis rate of breast cancer among local women. At the same time, the breast centers will also take advantage of Good Doctor's "Yandong (延动)" and "Kangfuxin Ye (康复新液)" in the field of breast nodulation and post-operative rehabilitation of breast cancer patients. The cooperation between both sides will integrate Chinese and western medicine to form a whole-cycle service model for breast health, to explore new and better solutions for the treatment and rehabilitation of breast cancer.

Aurora is an international innovator of modern medical technology, and Good Doctor is a leading enterprise of traditional Chinese medicine in China. The two sides have cooperated with each other to achieve the integration of traditional Chinese medicine for disease prevention and modern medical examination technology. Starting from breast cancer, a new generation of prevention and treatment system will be explored and developed, to promote evidence-based Chinese medicine, and to effectively solve the threat of breast cancer to women's health.

In the future, both sides will carry out evidence-based Chinese medicine evaluation and real-world research based on imaging in the breast center chain system; promote traditional Chinese medicine represented by " Yandong (延动)" and "Kangfuxin Ye (康复新液)" to enter the mainstream of breast cancer prevention and treatment services, jointly build a breast health service brand integrating traditional Chinese and western medicine, and work together to contribute to the "prevention, diagnosis, treatment and rehabilitation" for Chinese women's breast disease.